by Institute of Cancer Research Breast cancer cells. Patients with metastatic breast cancer carrying a particular mutation fare better on one form of hormone therapy than another and can be identified using a blood test, according to a new study. In a combined analysis of two major Phase III clinical trials, called SoFEA and EFECT, researchers were able to show...
Sponsored Content by Eisai This article is intended for Healthcare Professionals Breast Cancer ProgramIOB Institute of Oncology An interview with Dr Javier Cortes, Head of Breast Cancer Program, IOB Institute of Oncology, Madrid and Barcelona, Spain. When does breast cancer become “advanced”? There is a certain amount of debate surrounding the exact definition of advanced breast cancer (ABC). When we talk about clinical trials, it’s not easy to...
